Form 4 for GEHC GE HealthCare
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0000899243-23-001105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-05 | 2023-01-03 | GEHC | Rott Roland | CEO, Ultrasound | A - Grant | — | +245 | 245 | New | — |
| DM | 2023-01-05 | 2023-01-04 | GEHC | Rott Roland | CEO, Ultrasound | A - Grant | — | +75.4K | 735 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 245 | — | 245 | D | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 552 | — | 552 | D | $161.30 · — to 2026-09-30 | 552 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 919 | — | 919 | D | $99.21 · — to 2027-11-17 | 919 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 13,773 | — | 13,773 | D | $88.67 · — to 2028-01-29 | 13,773 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 1,639 | — | 1,639 | D | $76.66 · — to 2028-03-19 | 1,639 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 2,296 | — | 2,296 | D | $76.66 · — to 2028-03-19 | 2,296 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 13,275 | — | 13,275 | D | $40.40 · — to 2028-12-21 | 13,275 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,727 | — | 3,727 | D | $57.74 · — to 2029-03-19 | 3,727 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 1,614 | — | 1,614 | D | $51.67 · — to 2029-04-11 | 1,614 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 7,214 | — | 7,214 | D | $63.51 · — to 2030-03-02 | 7,214 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023. |
| 11 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 8,536 | — | 8,536 | D | $75.24 · — to 2031-04-01 | 8,536 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on April 1, 2023 and 50% will become exercisable on April 1, 2024. |
| 12 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 1,081 | — | 1,081 | D | — · — to — | 1,081 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F6) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. |
| 13 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 6,519 | — | 6,519 | D | — · — to — | 6,519 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F7) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. |
| 14 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 3,713 | — | 3,713 | D | — · — to — | 3,713 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F8) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. |
| 15 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 3,347 | — | 3,347 | D | — · — to — | 3,347 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F9) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024. |
| 16 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 5,828 | — | 5,828 | D | — · — to — | 5,828 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F10) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. |
| 17 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 643 | — | 643 | D | $142.15 · — to 2024-09-05 | 643 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 18 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 735 | — | 735 | D | $135.92 · — to 2025-09-11 | 735 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |